Anticoagulation with AV Accesses




(1)
Department of Vascular Surgery, Evangelisches Krankenhaus Königin Elisabeth Herzberge, Berlin, Germany

 



In our experience, the following course of action has proved useful:

(a)

With physiological circulatory conditions and normal coagulation, neither AV fistulas nor AV shunts require drugs that influence coagulation.

 

(b)

We start primary anticoagulation (INR around 3) only in patients with:



  • Confirmed hypercoagulability


  • Arterioarterial grafts


  • Hypotension (systolic RR < 80 mmHg) with prosthetic grafts

 

(c)

After thrombosis we proceed according to intraoperative findings at thrombectomy. Criteria comprise:



  • Arterial inflow and venous outflow resistance


  • Vascular morphology as shown by intraoperative angiography (which we recommend)


  • Kind of thrombus material (white, mixed, or red)


  • Anamnestic suspicion of possible expressed temporary hypotension (e.g., severe diarrhea with pre-existing hypotension, shock, general anesthesia)


  • Long-lasting compression of the vascular access (bandage, joint position)

Typical aspects of a coagulation disorder are white or mixed thrombi.

Without suspicion of a persistent



  • Hemodynamic,


  • Morphological, or


  • Coagulation-related
cause, we do not order extra tests or introduce additional drug therapy after thrombectomy, but observe the clinical course.

With suspicion of



  • A morphological cause (arterial or venous stenoses or occlusions)
we complete imaging studies and repair pathologic findings if possible.

With suspicion of



  • Hypercoagulability
we initiate further coagulation tests.



  • If they prove positive, we start with (oral) anticoagulants.


  • If they prove negative, we observe the clinical course. Should there be repeat thrombosis in the absence of other evident causes, we start with anticoagulants despite negative standard test results.

 

(d)

An increased hematocrite also means a higher blood viscosity. Nonetheless if erythropoietin therapy or transfusions are indicated, they should not be cancelled for fear of AV access occlusion. Their effect should only be risky as to access occlusion under already unstable conditions.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Apr 11, 2017 | Posted by in NEPHROLOGY | Comments Off on Anticoagulation with AV Accesses

Full access? Get Clinical Tree

Get Clinical Tree app for offline access